Advanced search×

Infection.

J Orthop Trauma 24(9):583-6 (2010) PMID 20736799

Musculoskeletal infection is a clinical problem with significant direct healthcare costs. The prevalence of infection after closed, elective surgery is frequently estimated to be less than 2%, but in severe injuries, posttraumatic infection rates have been reported as 10% or greater. Although clinical infections are found outside the realm of medical devices, it is clear that the enormous increase of infections associated with the use of implants presents a major challenge worldwide. This review summarizes recent advances in the understanding, diagnosis, and treatment of musculoskeletal infections.

DOI: 10.1097/BOT.0b013e3181eebf12
Version: za2963e q8za6 q8zb4 q8zc9 q8zdd q8zee q8zf4 q8zg7

Similar articles you may find interesting…

  1. Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human β-defensin, and...

    Peptides 32(5):859-67 (2011) PMID 21291939

    Our results indicate that KSL-W had no toxic effect on cell adhesion or growth, suggesting its safe use with human cells. Pre-treating C. albicans with KSL-W attenuated the yeast's virulence as demonstrated by its reduced adhesion and growth on engineered human oral mucosa epithelium and the subsequ...
  2. Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human @b-defensin, an...

    Peptides 32(5):859-67 (2011) PMID 21291939

    We investigated the toxicity of synthetic antimicrobial decapeptide KSL-W on normal human gingival epithelial cell cultures, its effect on Candida albicans adhesion and growth, and the activation of epithelial cell innate immunity. Our results indicate that KSL-W had no toxic effect on cell adhesion...
  3. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.

    FEMS Immunol Med Microbiol 59(3):306-23 (2010) PMID 20602638

    We will also use one of the better studied microbial species that uses differential, multifactorial protein profiles to mediate an array of diseases, Staphylococcus aureus, to outline some of the more recently identified problematic issues in vaccine development in this biofilm-forming species....